126 related articles for article (PubMed ID: 10617792)
1. Current laboratory assays and in vitro intracellular Th1 and Th2 cytokine synthesis in monitoring antiretroviral therapy of pediatric HIV infection.
Voiculescu C; Avrămescu C; Radu E; Balasoiu M; Turculeanu A
FEMS Immunol Med Microbiol; 2000 Jan; 27(1):67-71. PubMed ID: 10617792
[TBL] [Abstract][Full Text] [Related]
2. Relationship of in vivo and ex vivo levels of TH1 and TH2 cytokines with viremia in HAART patients with and without opportunistic infections.
Sindhu S; Toma E; Cordeiro P; Ahmad R; Morisset R; Menezes J
J Med Virol; 2006 Apr; 78(4):431-9. PubMed ID: 16482539
[TBL] [Abstract][Full Text] [Related]
3. Effect of two different combinations of antiretrovirals (AZT+ddI and AZT+3TC) on cytokine production and apoptosis in asymptomatic HIV infection.
Piconi S; Trabattoni D; Fusi ML; Milazzo F; Dix LP; Rizzardini G; Colombo F; Bray D; Clerici M
Antiviral Res; 2000 Jun; 46(3):171-9. PubMed ID: 10867155
[TBL] [Abstract][Full Text] [Related]
4. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group.
Collier AC; Coombs RW; Schoenfeld DA; Bassett RL; Timpone J; Baruch A; Jones M; Facey K; Whitacre C; McAuliffe VJ; Friedman HM; Merigan TC; Reichman RC; Hooper C; Corey L
N Engl J Med; 1996 Apr; 334(16):1011-7. PubMed ID: 8598838
[TBL] [Abstract][Full Text] [Related]
5. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
[TBL] [Abstract][Full Text] [Related]
6. IMMUNOLOGICAL PROFILES IN HIV POSITIVE PATIENTS FOLLOWING HAART INITIATION IN KIGALI, RWANDA.
Twizerimana AP; Mwatha J; Musabyimana JP; Kayigi E; Harelimana Jde D; Karanja SM; Mutesa L
East Afr Med J; 2014 Aug; 91(8):261-6. PubMed ID: 26862650
[TBL] [Abstract][Full Text] [Related]
7. The 48-week efficacy of once-daily saquinavir/ritonavir in patients with undetectable viral load after 3 years of antiretroviral therapy.
Cardiello P; Srasuebkul P; Hassink E; Mahanontharit A; Samor T; Ruxrungtham K; Lange J; Cooper D; Phanuphak P
HIV Med; 2005 Mar; 6(2):122-8. PubMed ID: 15807718
[TBL] [Abstract][Full Text] [Related]
8. TH1 and TH2 cytokine mRNA and protein levels in human immunodeficiency virus (HIV)-seropositive and HIV-seronegative youths.
Douglas SD; Durako S; Sullivan KE; Camarca M; Moscicki AB; Wilson CM
Clin Diagn Lab Immunol; 2003 May; 10(3):399-404. PubMed ID: 12738638
[TBL] [Abstract][Full Text] [Related]
9. Persistent alterations in T-cell repertoire, cytokine and chemokine receptor gene expression after 1 year of highly active antiretroviral therapy.
Martinon F; Michelet C; Peguillet I; Taoufik Y; Lefebvre P; Goujard C; Guillet JG; Delfraissy JF; Lantz O
AIDS; 1999 Feb; 13(2):185-94. PubMed ID: 10202824
[TBL] [Abstract][Full Text] [Related]
10. Liposomal Glutathione Supplementation Restores TH1 Cytokine Response to Mycobacterium tuberculosis Infection in HIV-Infected Individuals.
Ly J; Lagman M; Saing T; Singh MK; Tudela EV; Morris D; Anderson J; Daliva J; Ochoa C; Patel N; Pearce D; Venketaraman V
J Interferon Cytokine Res; 2015 Nov; 35(11):875-87. PubMed ID: 26133750
[TBL] [Abstract][Full Text] [Related]
11. The changes in the T helper 1 (Th1) and T helper 2 (Th2) cytokine balance during HIV-1 infection are indicative of an allergic response to viral proteins that may be reversed by Th2 cytokine inhibitors and immune response modifiers--a review and hypothesis.
Becker Y
Virus Genes; 2004 Jan; 28(1):5-18. PubMed ID: 14739648
[TBL] [Abstract][Full Text] [Related]
12. TH1/TH2 cytokine levels as an indicator for disease progression in human immunodeficiency virus type 1 infection and response to antiretroviral therapy.
Osakwe CE; Bleotu C; Chifiriuc MC; Grancea C; Oţelea D; Paraschiv S; Petrea S; Dinu M; Băicuş C; Streinu-Cercel A; Lazăr V
Roum Arch Microbiol Immunol; 2010; 69(1):24-34. PubMed ID: 21053781
[TBL] [Abstract][Full Text] [Related]
13. Reduction in interleukin-2-producing cells but not Th1 to Th2 shift in moderate and advanced stages of human immunodeficiency virus type-1-infection: direct analysis of intracellular cytokine concentrations in CD4+ CD8- T cells.
Tanaka M; Hirabayashi Y; Gatanaga H; Aizawa S; Hachiya A; Takahashi Y; Tashiro E; Kohsaka T; Oyamada M; Ida S; Oka S
Scand J Immunol; 1999 Nov; 50(5):550-4. PubMed ID: 10564559
[TBL] [Abstract][Full Text] [Related]
14. Multi-way flow cytometric immune monitoring of antiretroviral therapy in HIV-infected children.
Voiculescu C; Bălăşoiu M; Turculeanu A; Avrămescu C; Radu E
Roum Arch Microbiol Immunol; 1998; 57(2):99-110. PubMed ID: 11845433
[TBL] [Abstract][Full Text] [Related]
15. Th1/Th2 shift in HIV lymph nodes: no contribution of CD6o cells.
Bogner JR; Walli R; Goebel FD
Infection; 2001; 29(1):32-6. PubMed ID: 11261756
[TBL] [Abstract][Full Text] [Related]
16. Synergistic immunosuppression by candida in HIV infection: a cytokine based analysis.
Bajaj JS; Singh A; Aggarwal SK; Chattopadhya D; Baveja UK
J Commun Dis; 2000 Mar; 32(1):1-9. PubMed ID: 11186879
[TBL] [Abstract][Full Text] [Related]
17. Randomized, controlled phase II trial of subcutaneous interleukin-2 in combination with highly active antiretroviral therapy (HAART) in HIV patients.
Hengge UR; Goos M; Esser S; Exner V; Dötterer H; Wiehler H; Borchard C; Müller K; Beckmann A; Eppner MT; Berger A; Fiedler M
AIDS; 1998 Dec; 12(17):F225-34. PubMed ID: 9863864
[TBL] [Abstract][Full Text] [Related]
18. A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients.
Idoko JA; Akinsete L; Abalaka AD; Keshinro LB; Dutse L; Onyenekwe B; Lhekwaba A; Njoku OS; Kehinde MO; Wambebe CO
West Afr J Med; 2002; 21(2):83-6. PubMed ID: 12403023
[TBL] [Abstract][Full Text] [Related]
19. A randomized double-blind trial of the addition of lamivudine or matching placebo to current nucleoside analogue reverse transcriptase inhibitor therapy in HIV-infected children: the PENTA-4 trial. Paediatric European Network for Treatment of AIDS.
AIDS; 1998 Oct; 12(14):F151-60. PubMed ID: 9792371
[TBL] [Abstract][Full Text] [Related]
20. Do HIV type 1 RNA levels provide additional prognostic value to CD4(+) T lymphocyte counts in patients with advanced HIV type 1 infection?
Arduino JM; Fischl MA; Stanley K; Collier AC; Spiegelman D
AIDS Res Hum Retroviruses; 2001 Aug; 17(12):1099-105. PubMed ID: 11522179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
